Login
Related Links
Breaking Gene Therapy News
Breaking gene therapy news items collected via Google News. Current news results for 'gene therapy' are sorted by date. Login and view all archived news items.
- CRISPR-based gene therapy shows promise for muscular dystrophy - RegMedNet
Fri, 17 Jan 2025 15:26:1 GMT - Gene Therapy Market Demand Worldwide in 2025, by Region to 2032 | SkyQuest Technology - openPR
Fri, 17 Jan 2025 05:26:0 GMT - Sangamo Nearing Fabry Gene Therapy Deal To Fund Its Pipeline - insights.citeline.com
Fri, 17 Jan 2025 01:53:5 GMT - HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws' - Benzinga
Thu, 16 Jan 2025 20:10:3 GMT - Phase 2 trial of AskBio’s gene therapy assigns its first participants - Parkinson's News Today
Thu, 16 Jan 2025 17:59:2 GMT - Viral Vectors-Based Gene Therapy for Non-Human Primates to - GlobeNewswire
Thu, 16 Jan 2025 17:01:1 GMT - Gene Therapy in Hemophilia: High Hopes and Costs, Low Uptake - Medscape
Thu, 16 Jan 2025 10:08:0 GMT - Umoja raises $100 million to boost its CAR-T cell gene therapy pipeline - BioPharma-Reporter.com
Thu, 16 Jan 2025 08:56:1 GMT - Solid Biosciences Advances Gene Therapy Pipeline, Reports Strong $148.9M Cash Position - StockTitan
Wed, 15 Jan 2025 22:05:0 GMT - Fatal neurodegenerative disease in kids also affects the bowel—gene therapy may help - Medical Xpress
Wed, 15 Jan 2025 21:49:0 GMT - Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse models - Science
Wed, 15 Jan 2025 20:13:2 GMT - Roche Licenses Dyno Therapeutics’ AAV Vector for Neurological Gene Therapy - Genetic Engineering & Biotechnology News
Wed, 15 Jan 2025 18:17:3 GMT - Spark Therapeutics co-founder back at the helm of a Philadelphia gene therapy company - The Business Journals
Tue, 14 Jan 2025 21:00:0 GMT - Fresh off AbbVie update, Regenxbio inks $810M MPS gene therapy deal - FirstWord Pharma
Tue, 14 Jan 2025 16:22:1 GMT - RhyGaze raises $86 million to develop vision restoration gene therapy - Healio
Tue, 14 Jan 2025 15:42:2 GMT - FDA gives go-ahead for clinical testing of FA gene therapy SGT-212 - Friedreich's Ataxia News
Tue, 14 Jan 2025 14:51:2 GMT - Long-term potential revealed for novel modifier gene therapy - European Pharmaceutical Review
Tue, 14 Jan 2025 12:57:3 GMT - Meet the California Institute Pushing Stem Cell and Gene Therapy Research: Part 2 - The Medicine Maker
Tue, 14 Jan 2025 12:49:5 GMT - RegenXBio sells Hunter syndrome gene therapy's U.S., Asia commercial rights for $110M upfront - Fierce Biotech
Tue, 14 Jan 2025 11:56:2 GMT - REGENXBIO Lands $810M Gene Therapy Deal with Nippon Shinyaku for Rare Disease Treatments - StockTitan
Tue, 14 Jan 2025 11:00:0 GMT - First participants randomized in AskBio Phase II gene therapy trial for Parkinson’s disease - Bayer
Tue, 14 Jan 2025 08:29:4 GMT - Durham biotech startup raises $175 million as it starts novel gene therapy trial - Raleigh News & Observer
Tue, 14 Jan 2025 00:08:0 GMT - JPM25: Deals, Summit’s bravado and gene therapy headwinds - BioPharma Dive
Mon, 13 Jan 2025 23:36:3 GMT - FDA Clears Solid Biosciences Neurodegeneration Gene Therapy IND - Inside Precision Medicine
Mon, 13 Jan 2025 15:00:2 GMT - Ocugen's Gene Therapy Shows 100% Success Rate in 2-Year Vision Loss Treatment Trial - StockTitan
Mon, 13 Jan 2025 12:30:0 GMT - Ocugen, Inc. Announces Positive 2-Year Data Across Multiple Mutations from Phase 1/2 Clinical Trial of OCU400 —A Novel Modifier Gene Therapy for Retinitis Pigmentosa - Yahoo Finance
Mon, 13 Jan 2025 12:30:0 GMT - Hope for the Haslams: UNM offered $6 million gene therapy treatment to two young Rio Rancho brothers - Rio Rancho Observer
Sun, 12 Jan 2025 18:07:1 GMT - Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration - Business Wire
Fri, 10 Jan 2025 14:00:0 GMT - XyloCor Therapeutics Raises $67.5 Million in Series B Financing to Advance Clinical Development of Novel Gene Therapy in Cardiovascular Disease - Business Wire
Tue, 07 Jan 2025 13:30:0 GMT - AbbVie exercises $40M option for Capsida-partnered gene therapy - Fierce Biotech
Tue, 07 Jan 2025 09:00:0 GMT